BioAdaptives Inc. (OTC: BDPT) is a dietary supplement and nutraceutical company that develops and sells consumer health products targeting cognitive enhancement, weight management, and pet wellness. The company sells directly to consumers through its own digital channels and generates revenue through direct-to-consumer e-commerce, telehealth platform partnerships, and an affiliate marketing program that uses social media influencers. Its product portfolio includes MyndMed (cognitive health), Zeranovia (weight loss), Wynovia (lean muscle retention during dieting), and PawPa Regen, a canine nutraceutical chew. The company also holds marketing rights to the Lung Flute, an FDA-cleared Class II medical device acquired in April 2024. BioAdaptives has never paid a cash dividend, carries convertible note obligations with derivative liabilities on its balance sheet, and reported net losses for both fiscal years ended December 31, 2025 and December 31, 2024. As of March 21, 2025, the company was incorporated in Delaware and had no independent directors on its board.

Revenue model

Direct-to-consumer e-commerce sales of dietary supplements, affiliate marketing partnerships with influencers and third-party companies, and distribution through telehealth platform integrations. The filing does not disclose specific revenue figures or segment breakdowns.

Products and services

MyndMed (cognitive health supplement), Zeranovia (weight loss supplement), Wynovia (lean muscle retention supplement), PawPa Regen (canine nutraceutical chew targeting regenerative support and anti-aging), and Lung Flute (FDA-cleared Class II medical device, marketing rights acquired April 2024).

Customers and end markets

Health-conscious direct-to-consumer buyers, telehealth platform participants, and pet owners. The filing does not disclose customer counts, customer concentration figures, or segment-level end market data.

Value-chain role

Product developer and direct-to-consumer marketer of proprietary dietary supplements and nutraceuticals. The company uses affiliate and influencer networks for distribution and telehealth platforms as a channel partner. The filing references proprietary formulation methods and patent assets, including amortization of license and patent costs.

Geographic exposure

The filing does not specify geographic revenue breakdown. The company is incorporated in Delaware and headquartered in the United States.

Source: SEC 10-K, filed 2026-04-14

Industry: Pharmaceutical Preparations